These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 22172892

  • 1. Hyperkalemic distal renal tubular acidosis caused by immunosuppressant treatment with tacrolimus in a liver transplant patient: case report.
    Riveiro-Barciela M, Campos-Varela I, Tovar JL, Vargas V, Simón-Talero M, Ventura-Cots M, Crespo M, Bilbao I, Castells L.
    Transplant Proc; 2011 Dec; 43(10):4016-8. PubMed ID: 22172892
    [Abstract] [Full Text] [Related]

  • 2. A case of hyperkalemic distal renal tubular acidosis secondary to tacrolimus in living donor liver transplantation.
    Oishi M, Yagi T, Urushihara N, Takakura N, Inagaki M, Sadamori H, Mastukawa H, Inoue T, Oda S, Tanaka N.
    Transplant Proc; 2000 Nov; 32(7):2225-6. PubMed ID: 11120143
    [No Abstract] [Full Text] [Related]

  • 3. Proximal renal tubular acidosis secondary to FK506 in pediatric liver transplant patients.
    O'Gorman MA, Fivush B, Wise B, Colombani P, Burdick J, Schwarz KB.
    Clin Transplant; 1995 Aug; 9(4):312-6. PubMed ID: 7579739
    [Abstract] [Full Text] [Related]

  • 4. Type 4 renal tubular acidosis in a kidney transplant recipient.
    Kulkarni M.
    Biomed J; 2016 Feb; 39(1):85-6. PubMed ID: 27105603
    [Abstract] [Full Text] [Related]

  • 5. Renal tubular acidosis secondary to FK506 in living donor liver transplantation: a case report.
    Ogita K, Takada N, Taguchi T, Suita S, Soejima Y, Suehiro T, Shimada M, Maehara Y.
    Asian J Surg; 2003 Oct; 26(4):218-20. PubMed ID: 14530108
    [Abstract] [Full Text] [Related]

  • 6. Distal tubular acidosis induced by FK506.
    Heering P, Ivens K, Aker S, Grabensee B.
    Clin Transplant; 1998 Oct; 12(5):465-71. PubMed ID: 9787958
    [Abstract] [Full Text] [Related]

  • 7. Severe rhabdomyolysis and acute renal failure secondary to concomitant use of simvastatin with rapamycin plus tacrolimus in liver transplant patient.
    Dopazo C, Bilbao I, Lázaro JL, Sapisochin G, Caralt M, Blanco L, Castells L, Charco R.
    Transplant Proc; 2009 Apr; 41(3):1021-4. PubMed ID: 19376416
    [Abstract] [Full Text] [Related]

  • 8. Renal Tubular Acidosis and Management Strategies: A Narrative Review.
    Palmer BF, Kelepouris E, Clegg DJ.
    Adv Ther; 2021 Feb; 38(2):949-968. PubMed ID: 33367987
    [Abstract] [Full Text] [Related]

  • 9. Clinical analysis of hyperkalemic renal tubular acidosis caused by calcineurin inhibitors in solid organ transplant recipients.
    Lin W, Mou L, Tu H, Zhu L, Wang J, Chen J, Hu Y.
    J Clin Pharm Ther; 2017 Feb; 42(1):122-124. PubMed ID: 27966241
    [Abstract] [Full Text] [Related]

  • 10. Severe hyperkalemic type 4 renal tubular acidosis after kidney transplantation: a case report.
    Rangel EB, Gomes SA, Machado PG, dos Santos BF, Pestana JO, Pacheco-Silva A, Heilberg IP.
    Transplant Proc; 2006 Nov; 38(9):3112-5. PubMed ID: 17112912
    [Abstract] [Full Text] [Related]

  • 11. Hyperkalemic Forms of Renal Tubular Acidosis: Clinical and Pathophysiological Aspects.
    Batlle D, Arruda J.
    Adv Chronic Kidney Dis; 2018 Jul; 25(4):321-333. PubMed ID: 30139459
    [Abstract] [Full Text] [Related]

  • 12. Sirolimus and mycophenolate mofetil after liver transplantation.
    Kniepeiss D, Iberer F, Grasser B, Schaffellner S, Tscheliessnigg KH.
    Transpl Int; 2003 Jul; 16(7):504-9. PubMed ID: 12687325
    [Abstract] [Full Text] [Related]

  • 13. Renal tubular acidosis type IV as a complication of lupus nephritis.
    Sánchez-Marcos C, Hoffman V, Prieto-González S, Hernández-Rodríguez J, Espinosa G.
    Lupus; 2016 Mar; 25(3):307-9. PubMed ID: 26345674
    [Abstract] [Full Text] [Related]

  • 14. The calcineurin inhibitor FK506 (tacrolimus) is associated with transient metabolic acidosis and altered expression of renal acid-base transport proteins.
    Mohebbi N, Mihailova M, Wagner CA.
    Am J Physiol Renal Physiol; 2009 Aug; 297(2):F499-509. PubMed ID: 19439519
    [Abstract] [Full Text] [Related]

  • 15. Late fulminant posterior reversible encephalopathy syndrome after liver transplant.
    Heidenhain C, Puhl G, Neuhaus P.
    Exp Clin Transplant; 2009 Sep; 7(3):180-3. PubMed ID: 19715529
    [Abstract] [Full Text] [Related]

  • 16. Tubular dysfunction in renal transplant patients using sirolimus or tacrolimus.
    Banhara PB, Gonçalves RT, Rocha PT, Delgado AG, Leite M, Gomes CP.
    Clin Nephrol; 2015 Jun; 83(6):331-7. PubMed ID: 25943142
    [Abstract] [Full Text] [Related]

  • 17. A physiology-based approach to a patient with hyperkalemic renal tubular acidosis.
    Menegussi J, Tatagiba LS, Vianna JGP, Seguro AC, Luchi WM.
    J Bras Nefrol; 2018 Jun; 40(4):410-417. PubMed ID: 30048563
    [Abstract] [Full Text] [Related]

  • 18. [Distal tubular acidosis. Recent data].
    Paillard M, Houillier P, Borensztein P, Prigent A.
    Nephrologie; 1991 Jun; 12(3):125-30. PubMed ID: 1656291
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of renal function in liver transplant recipients receiving daclizumab (Zenapax), mycophenolate mofetil, and a delayed, low-dose tacrolimus regimen vs. a standard-dose tacrolimus and mycophenolate mofetil regimen: a multicenter randomized clinical trial.
    Yoshida EM, Marotta PJ, Greig PD, Kneteman NM, Marleau D, Cantarovich M, Peltekian KM, Lilly LB, Scudamore CH, Bain VG, Wall WJ, Roy A, Balshaw RF, Barkun JS.
    Liver Transpl; 2005 Sep; 11(9):1064-72. PubMed ID: 16123958
    [Abstract] [Full Text] [Related]

  • 20. Tacrolimus-Induced Type IV Renal Tubular Acidosis following Liver Transplantation.
    Schmoyer C, Mishra S, Fulco F.
    Case Reports Hepatol; 2017 Sep; 2017():9312481. PubMed ID: 28761769
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.